Clinical outcome and safety of holmium laser prostate enucleation after transrectal prostate biopsies for benign prostatic hyperplasia
Investigative and Clinical Urology · 2024
DOI: 10.4111/icu.20230276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative and Clinical Urology, 2024. Verfasst von See Min Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Lasers, Solid-State, Transurethral Resection of Prostate. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
PURPOSE: This study aimed to assess the clinical outcome and safety of holmium laser enucleation of the prostate (HoLEP) following transrectal ultrasound-guided prostate biopsy (TR biopsy) in the treatment of benign prostate hyperplasia. MATERIALS AND METHODS: We retrospectively analyzed data from 556 patients who underwent HoLEP between 2014 and 2021. The patients were categorized into six groups: Group 1-A (n=45) underwent HoLEP within four months post TR biopsy. Group 1-B (n=94) underwent HoLEP more than four months post TR biopsy. Group 1-C (n=120) underwent HoLEP after a single TR biopsy. Group 1-D (n=19) underwent HoLEP after two or more TR biopsies. Group 1-total (n=139, group 1-A+group 1-B or group 1-C+group 1-D) underwent HoLEP post TR biopsy. Group 2 (control group, n=417) underwent HoLEP without prior TR biopsy. We examined perioperative parameters, safety, and functional outcomes. RESULTS: The age, body mass index, International Prostate Symptom Score (IPSS), uroflowmetry, and comorbid diseases between group 1-total and group 2 were comparable. However, group 1-total exhibited significantly elevated prostate-specific antigen levels and larger prostate volumes (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
- Institute of Health Science, Gyeongsang National University, Jinju, Korea.
- Department of Urology, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea.
- Institute of Health Science, Gyeongsang National University, Jinju, Korea. hyunjs@gnu.ac.kr.
ORCID-Profile: See Min Choi, Chang Seok Kang, Dae Hyun Kim, Jae Hwi Choi, Chunwoo Lee, Seong Uk Jeh, Sung Chul Kam, Jeong Seok Hwa, Jae Seog Hyun
Zitieren
APA
Choi, S. M., Kang, C. S., Kim, D. H., Choi, J. H., Lee, C., Jeh, S. U., Kam, S. C., Hwa, J. S., & Hyun, J. S. (2024). Clinical outcome and safety of holmium laser prostate enucleation after transrectal prostate biopsies for benign prostatic hyperplasia. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20230276
Vancouver
Choi SM, Kang CS, Kim DH, Choi JH, Lee C, Jeh SU, et al. Clinical outcome and safety of holmium laser prostate enucleation after transrectal prostate biopsies for benign prostatic hyperplasia. Investigative and Clinical Urology. 2024. doi:10.4111/icu.20230276
BibTeX
@article{Choi2024,
author = {Choi, See Min and Kang, Chang Seok and Kim, Dae Hyun and Choi, Jae Hwi and Lee, Chunwoo and Jeh, Seong Uk and Kam, Sung Chul and Hwa, Jeong Seok and Hyun, Jae Seog},
title = {Clinical outcome and safety of holmium laser prostate enucleation after transrectal prostate biopsies for benign prostatic hyperplasia},
journal = {Investigative and Clinical Urology},
year = {2024},
doi = {10.4111/icu.20230276}
}
EUVIMED